Inventor · disambiguated record
Emmanuel Meyer
Also filed as: MEYER EMMANUEL
12 granted patents·3 pending applications·54 citations·filing 2006–2022
88Inventor score
Top patents by PatentIndex Score
15 records- 0188US8058263B2Substituted 2-phenyl-pyridine derivativesCAROFF EVA·Filed 2009·Granted Nov 15, 2011·9 cites·19 claims
- 0284US8518912B2Phosphonic acid derivates and their use as P2Y12 receptor antagonistsCAROFF EVA·Filed 2008·Granted Aug 27, 2013·9 cites·39 claims
- 0384US8048881B2Pyrimidine derivatives and their use as P2Y12 receptor antagonistsACTELION PHARMACEUTICALS LTD·Filed 2006·Granted Nov 1, 2011·9 cites·16 claims
- 0482US8664203B2Thiazole derivatives and their use as P2Y12 receptor antagonistsCAROFF EVA·Filed 2010·Granted Mar 4, 2014·4 cites·14 claims
- 0582US8288385B26-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidinesCAROFF EVA·Filed 2010·Granted Oct 16, 2012·7 cites·16 claims
- 0681US8044055B22-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptorACTELION PHARMACEUTICALS LTD·Filed 2007·Granted Oct 25, 2011·5 cites·12 claims
- 0780US8466156B22-phenyl-4-cyclopropyl-pyrimidine derivativesCAROFF EVA·Filed 2009·Granted Jun 18, 2013·5 cites·10 claims
- 0875US9266876B24-(benzoimidazol-2-yl)-thiazole compounds and related aza derivativesACTELION PHARMACEUTICALS LTD·Filed 2013·Granted Feb 23, 2016·5 cites·41 claims
- 0969US10047080B2(R)-2-methyl-piperazine derivatives as CXCR3 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2016·Granted Aug 14, 2018·1 cites·14 claims
- 1061US2025042881A1Ccr6 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1161US2025011313A1Ccr6 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1251US2023174514A1Azetidin-3-ylmethanol derivatives as ccr6 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1346US10259807B21-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2014·Granted Apr 16, 2019·0 cites·16 claims
- 1437US10053457B2Hydroxyalkyl-piperazine derivatives as CXCR3 receptor modulatorsIDORSIA PHARMACEUTICALS LTD·Filed 2016·Granted Aug 21, 2018·0 cites·21 claims
- 1528US9951063B28-(piperazin-1-yl)-1,2,3,4-tetrahydro-isoquinoline derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Apr 24, 2018·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Emmanuel Meyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →